Status:
RECRUITING
Co-design of a Seamless Person-centered Intervention to Optimize Medication Use Across Healthcare Levels
Lead Sponsor:
Malin Olsen Syversen
Collaborating Sponsors:
Oslo University College
Oslo University Hospital
Conditions:
Multimorbidity
Eligibility:
All Genders
18+ years
Brief Summary
Multiple long term conditions entails various needs for complex medication treatment, which is a huge clinical challenge considering medication interactions and disease-medication interactions. It mig...
Detailed Description
Our research group has previously completed the OPERA- and PERLE-studies, which explore the effect of a pharmacist intervention at the hospital and medication communication at hospital discharge from ...
Eligibility Criteria
Inclusion
- Patients:
- Adult ≥ 18 years
- Gives written, informed consent to participate in the study. If the patient is not competent to consent, consent can be obtained from the patient's next of kin.
- Residential address in Oslo
- Lives at home and normally manage their medications themselves (might have help from home-care nurses or next of kin)
- Scheduled to be discharged from the wards to their home or to short-term stay in nursing homes
- Uses at least four regular medications from at least two therapy classes (Anatomical Therapeutic Chemical (ATC) at first level
- Health care personnel (HCP) and next of kin:
- Expected to be involved in the included patient's medication regime or management after hospital discharge
- Able and willing to give written, informed consent to participate in the study
- HCP should be general practitioners (GPs) or home-care nurses.
Exclusion
- Patients:
- Terminal and/or isolated due to infections
- Has previously been included in the study
- Has advanced cognitive failure, in accordance with assessment from treating physician
- Will not be discharged from the included wards to their homes (for example planned transfer to another ward or long-term stay at nursing home)
- Unable to communicate in Norwegian or English
- HCP and next of kin:
- Unable to communicate in Norwegian or English
- HCP or next of kin that has previously been included in the study
Key Trial Info
Start Date :
September 29 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05421143
Start Date
September 29 2022
End Date
April 1 2027
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, 0484